Orthopaedic implant with porous structural member
An orthopaedic implant includes an implant body having a first surface, a second surface opposite the first surface, and a cavity formed therein that extends through the first surface and the second surface. The implant body has a third surface with at least one first opening formed therethrough to the cavity. The at least one first opening includes an outer portion having an outer diameter and an inner portion having an inner diameter. The implant includes a load bearing member including a porous material held within the cavity. The outer portion of the at least one first opening is configured to couple to a tool for receiving, from the tool, a material agent, and the inner portion of the at least one first opening is configured to couple to a plug for preventing the material agent from exiting the porous material via the at least one first opening.
Latest SMed-TA/TD, LLC Patents:
This is a continuation-in-part application based on U.S. patent application Ser. No. 15/626,596 entitled “ORTHOPAEDIC IMPLANT WITH POROUS STRUCTURAL MEMBER,” filed Jun. 19, 2017, which is incorporated herein by reference. U.S. patent application Ser. No. 15/626,596 is a division of U.S. patent application Ser. No. 14/637,142 entitled “ORTHOPAEDIC IMPLANT WITH POROUS STRUCTURAL MEMBER”, filed Mar. 3, 2015, which is incorporated herein by reference. U.S. patent application Ser. No. 14/637,142 is a continuation-in-part application based upon U.S. patent application Ser. No. 12/540,515, entitled “ORTHOPAEDIC IMPLANT WITH POROUS STRUCTURAL MEMBER”, filed Aug. 13, 2009, which is incorporated herein by reference. U.S. patent application Ser. No. 12/540,515 is based upon U.S. provisional patent application Ser. No. 61/088,460, entitled “SPINAL DEVICES”, filed Aug. 13, 2008, which is incorporated herein by reference.
BACKGROUND OF THE INVENTION1. Field of the Invention
The present invention relates to orthopaedic devices, and, more particularly, to orthopaedic implants.
2. Description of the Related Art
Most orthopaedic implants are formed from a metallic material suitable for a given implant, such as a hip implant, knee implant, glenoid implant, etc. In the case of articulating joints, the implant may include a non-metallic load bearing surface, such as an ultra high molecular weight polyethylene (UHMWPE). The UHMWPE is attached to the metallic body of the implant, and provides the implant with good wear characteristics and low friction.
It is also known to provide an implant with a porous bony ingrowth surface. For example, a hip implant may include a porous surface on the stem which is intended to allow bony ingrowth of the proximal end of the femur bone. Such a porous surface may be in the form of a metal porous surface which is bonded, such as by heat sintering, to the stem of the implant. Examples of porous surfaces of this type include a woven mesh, a fiber mesh and particles. Knee implants are also known that include porous ingrowth surfaces that can bear load from surrounding anatomic structures.
Porous surfaces of the type described above which are used with implants are not typically part of a single structural member with two opposed, external porous surfaces. For example, in a knee implant, the distal surface of the implant can sit on the porous material that is slightly above the substrate material, but the porous material only typically has one external surface for tissue ingrowth. For hip implants, the porous ingrowth surface is usually provided as a coating on a structural component of the implant, such as the stem.
In some orthopaedic applications, such as spinal cages, it is beneficial to have a porous member that extends between two external, load bearing surfaces of the implant. In such arrangements, a cavity is typically formed between the two external surfaces of the implant and filled with a porous ingrowth material, which is typically a natural substance such as cancellous bone tissue. Such an implant is described in U.S. Patent Application No. 2002/0091447 to Shimp et al. One problem with the implant described by Shimp et al. is that harvesting sufficient cancellous bone tissue to fill the cavity is expensive, and host rejection issues can be a concern. Other similar implants that contemplate utilizing natural or synthetic materials are described in U.S. Patent Application Publication No. 2004/0210316 to King et al., and U.S. Pat. No. 6,423,095 to Van Hoeck et al. In each of these described implants, the porous material held in the cavity is fairly isolated from bearing load from surrounding anatomic structures after implantation, with external surfaces that are either flush or below the most protruding external surface of the main implant body. This is intentional, as the materials placed in the cavity tend to have significantly lower strength than the implant body. However, isolating the porous ingrowth material from bearing loads from surrounding anatomic structures also decreases the amount of surface area the porous ingrowth material has in contact with the anatomic structures, which can slow down integration of the implant. In addition, the porous materials placed in the cavity are typically resorbable by the body and will not last throughout the life of the implant.
Porous materials in a cavity of an implant may be loaded with one or more types of biological agents, to assist with the healing of nearby anatomical structures or tissues, or to protect against infections, or to fight disease, via the absorption of the agent by the surrounding tissue via the pores of the porous material. However, problems exist with expulsion of the agent from the pores after loading the porous material with the agent and prior to implantation of the implant, and of leakage of the agent through the opening via which the implant was initially loaded, particularly if the agent was loaded into the implant after the implant was positioned in the body.
What is needed in the art is an orthopaedic implant and associated devices and methods that can overcome some of the disadvantages of known implants and methods.
SUMMARY OF THE INVENTIONIn accordance with an aspect of the present invention, there is provided an orthopaedic implant including an implant body having a first surface, a second surface opposite the first surface, and a cavity formed therein that extends through the first surface and the second surface. The implant body is substantially non-porous, and further includes a third surface with at least one first opening formed therethrough to the cavity. The at least one first opening includes an outer portion having an outer diameter and an inner portion having an inner diameter. The outer diameter is greater than the inner diameter. The implant further includes a load bearing member including a substantially porous material held within the cavity, and the substantially porous material is configured to receive, via the at least one first opening, a material agent. The load bearing member has a first contact surface extending out of the cavity past the first surface. The outer portion of the at least one first opening is configured to couple to a tool for receiving, from the tool, the material agent, and the inner portion of the at least one first opening is configured to couple to a plug for preventing the material agent, once received by the substantially porous material via the at least one first opening from the tool, from exiting the substantially porous material via the at least one first opening.
In accordance with an aspect of the present invention, there is provided a tool configured for use with an orthopaedic implant. The orthopaedic implant includes an implant body having a first surface, a second surface opposite the first surface, a cavity formed therein that extends through the first surface and the second surface, the implant body being substantially non-porous and further including a third surface with at least one first opening formed therethrough to the cavity and at least one second opening, the at least one first opening comprising an threaded outer portion having an outer diameter and an threaded inner portion having an inner diameter, the outer diameter greater than the inner diameter. The implant further includes a load bearing member including a substantially porous material held within the cavity, the load bearing member configured to receive, via the at least one first opening, a material agent, the load bearing member having a first contact surface extending out of the cavity past the first surface. The tool includes a tubular assembly having a tubular passage including a first end and a second end, the first end having a means for attachment to the implant body, a plug, and a plunger coupled to the plug. The tubular passage is configured to receive, via the second end, the material agent and the plunger coupled to the plug. The plunger coupled to the plug is configured to slide through the tubular passage for expelling the material agent from the tubular passage into the load bearing member via the at least one first opening. The plunger coupled to the plug is also configured to rotate within the tubular passage for coupling the plug with the first opening to seal the first opening against expulsion of the material agent from the load bearing member via the first opening.
In accordance with an aspect of the present invention, there is provided a method of charging an orthopaedic implant with a material agent. The orthopaedic implant includes an implant body having a first surface, a second surface opposite the first surface, a cavity formed therein that extends through the first surface and the second surface, the implant body being substantially non-porous and further including a third surface with at least one first opening formed therethrough to the cavity and at least one second opening, the at least one first opening comprising an threaded outer portion having an outer diameter and an threaded inner portion having an inner diameter, the outer diameter greater than the inner diameter. The implant further includes a load bearing member including a substantially porous material held within the cavity, the load bearing member configured to receive, via the at least one first opening, a material agent, the load bearing member having a first contact surface extending out of the cavity past the first surface. The method includes coupling a tubular assembly to the third surface of the implant body, wherein the tubular assembly includes a tubular passage having a first end and a second end, and wherein the first end is coupled to the third surface such that said tubular passage is centered on the at least one first opening, placing the material agent into the tubular passage via the second end, sliding a plunger coupled to a plug through the tubular passage via the second end, thereby expelling the material agent from the tubular passage into the load bearing member via the at least one first opening, and rotating the plunger within the tubular passage for coupling the plug with the at least one first opening for sealing the at least one first opening against expulsion of the material agent from the load bearing member via the first opening.
An advantage of the present invention is that the orthopaedic implant can be initially charged with a material agent before or after the implant is placed in the body, or re-charged with the material agent during a second surgical procedure.
Another advantage of the present invention is that one or more openings of the orthopaedic implant, through which the implant is charged with the material agent, can be sealed against leakage or expulsion of the material agent from the implant.
The above-mentioned and other features and advantages of this invention, and the manner of attaining them, will become more apparent and the invention will be better understood by reference to the following description of embodiments of the invention taken in conjunction with the accompanying drawings, wherein:
The exemplifications set out herein illustrate embodiments of the invention, and such exemplifications are not to be construed as limiting the scope of the invention in any manner.
DETAILED DESCRIPTION OF THE INVENTIONI. Porous Spinal Devices—Laminate Designs
The present invention provides a laminate method for a spinal implant or implant component, including manufacturing methods for sheet creation, bonding/assembly methods, and ways of creating tapers. Further, the present invention provides delivery of therapeutic agents through a spinal device.
The present invention addresses these issues by providing the design and method of manufacturing of a porous spinal fusion device.
A. Materials
Material options for the spinal device include the following: implantable polymers (such as PEEK, PMMA), implantable reinforced polymers (such as carbon-fiber reinforced PEEK), implantable metals (such as titanium, titanium alloy), and implantable ceramics (such as hydroxyapatite, alumina). One or more of these materials can be combined in a given device.
B. Overall Design
With regard to the overall design, the implant can include entirely porous material or one or more porous regions and one or more solid regions. Additionally, an entirely porous device can be created to mate with existing solid devices (See
The porous region is created by stacking layers of material with interconnecting holes/geometry (hereafter referred to as holes).
The solid region can be formed by traditional techniques such as injection molding or machining or by bonding solid sheets together. The later method allows the solid and porous regions to be created from continuous sheets (See
The holes in the sheets can be created by, for example, laser cutting, punching, etching, electrical discharge machining, plasma etching, electroforming, electron beam machining, water jet cutting, stamping, or machining. For polymer based materials, they can be created as the sheets are created by, for example, extruding, injection molding, or hot stamping.
Attachment of the sheets to each other can be achieved by any number of ways, including the following:
1. Heat. Heat can be generated by several ways:
-
- a. Ultrasonic welding—use ultrasonic waves to create heat at the interface of layers.
- b. Heat staking—use a heated tool to cause melting between the layers
- c. Vibratory welding
- d. Laser welding
- e. Convection—use an oven to create heat to cause bonding
- f. Intermediary layer—for example, use a material that can absorb energy waves that pass through the polymer (for example PEEK) without causing damage. The absorbed energy will cause localized heating. An example of such a coating is Clearweld by Gentex® Corporation. The laser waves that Clearweld absorbs pass through the PEEK without causing damage, allowing the layers to be melted together without large scale damage to the PEEK.
2. Chemical.
-
- a. Adhesives—a secondary material (such as adhesive) can be used to bond the material.
- b. Solvent bonding—a material in which the polymer or reinforced polymer is soluble can be applied to the sheet surfaces allowing multiple surfaces to be bonded to one another.
- c. Overmolding—overmolding of the polymer or reinforced polymer can provide a chemical bonding
3. Mechanical.
-
- a. Overmolding—overmolding of a polymer or reinforced polymer can create a mechanical lock between components on a micro or macro scale (microscale—the molded material locks with surface asperities of the existing material. Macroscale—features such as tongue-groove connections or undercuts). The overmolded material can be a separate component from the layers or one layer can be overmolded onto another layer.
- b. Features are provided within the layers or by a separate component which provides a mechanical lock—e.g. A pin, snap lock connection, dove-tail, tongue-groove, rivet, screw and/or melting tabs to create a mechanical lock. For example, one or more rivets can connect all layers of a porous implant together. These connection features can be made of any implantable material including, but not limited to, titanium, titanium alloy, PEEK, and/or other implantable polymers. These features can also be used as radiopaque markers as is described below.
- c. Some adhesives provide a mechanical bond in addition to or instead of a chemical bond.
4. Combinations of Any/All of the Above Methods.
If the porous and solid regions are created separately (as in
1. Heat. Heat can be generated by several ways:
-
- a. Ultrasonic welding—use ultrasonic waves to create heat at the interface of layers.
- b. Heat staking—use a heated tool to cause melting between the layers
- c. Vibratory welding
- d. Laser welding
- e. Convection—use an oven to create heat to cause bonding
- f. Intermediary layer—for example, use a material that can absorb energy waves that pass through the polymer (for example PEEK) without causing damage. The absorbed energy will cause localized heating. An example of such a coating is Clearweld by Gentex® Corporation. The laser waves that Clearweld absorbs pass through the PEEK without causing damage, allowing the layers to be melted together without large scale damage to the PEEK.
2. Chemical.
-
- a. Adhesives—a secondary material (such as adhesive) can be used to bond the material.
- b. Solvent bonding—a material in which the polymer or reinforced polymer is soluble can be applied to the sheet surfaces allowing multiple surfaces to be bonded to one another.
- c. Overmolding—overmolding of the polymer or reinforced polymer can provide a chemical bonding
3. Mechanical.
-
- a. Overmolding—overmolding of a polymer or reinforced polymer can create a mechanical lock between components on a micro or macro scale (microscale—the molded material locks with surface asperities of the existing material. Macroscale—features such as tongue-groove connections or undercuts). The overmolded material can be a separate component from the layers or one layer can be overmolded onto another layer.
- b. Features are provided within the layers or by a separate component which provides a mechanical lock—e.g. A pin, snap lock connection, dove-tail, tongue-groove, rivet, and/or melting tabs to create a mechanical lock. For example, the porous material can attach to the windows that are typical in spinal cages or to a groove or ledge is created along the interior edge of the solid ring (see
FIGS. 5-10 ). These connection features can be made of any implantable material including, but not limited to, titanium, titanium alloy, PEEK, and/or other implantable polymers. These features can also be used as radiopaque markers as is discussed later in this disclosure. - c. Some adhesives provide a mechanical bond in addition to or instead of a chemical bond.
4. Combinations of any/all of the above methods.
Assembly of layer to layer or one component to another (for example a porous component to a solid component) can be aided by such ways as surface modifications to improve adhesive or solvent bonding or roughened surfaces.
The laminate portion of the implant can have layers oriented in any direction. For example, the layers can be perpendicular, parallel, or at an angle to the axis of the implant (See
The overall shape of the implant can be of any typical existing type, such as ALIF, TLIF, PLIF, and standard round cages (see
C. Delivery of Therapeutic Agent.
This device can be used to deliver therapeutic agents directly to the tissue surrounding the implant (See
The implant can include a reservoir for delivery of the therapeutic agent over an extended period of time. Openings leading from the reservoir to the porous material allow for controlled release of the therapeutic agents at a desired rate. The reservoir can be refilled at any time before, during, or after the surgery.
If immediate delivery of the therapeutic agents to the surrounding tissue is all that is required (not extended time release), the design need not include a reservoir. In this case, the therapeutic agents can be directly routed from the implant access to the porous material via channels. However, a reservoir can be included in an immediate delivery design; the openings in the reservoir would be sized to allow for immediate release of the therapeutic agent rather than a slower, long-term delivery.
The access in the implant (see
In order to allow and promote bone growth through the implant from one vertebra to the other, openings run from the superior to the inferior portion of the implant and be appropriately sized to allow for bone ingrowth (See
D. Anterior-Posterior Taper
Some implants are tapered to mate with the natural anterior-posterior taper that exists between vertebrae. If a solid portion exists, this taper can be created by traditional machining and/or molding techniques. In the porous region, there are several ways of creating this taper, including the following:
-
- a. If the design includes a reservoir, the reservoir itself can be tapered. The porous ingrowth layers can be of uniform thickness and layered outside of the reservoir (as indicated in
FIG. 18 ). - b. A wedge-shaped piece or pieces can create the taper with the ingrowth layers stacked on the wedge(s). This is essentially the same design as shown in
FIG. 20 without the reservoir, access and holes for the therapeutic agent delivery. To allow and promote bone growth through the implant from one vertebra to the other, openings run from the superior to the inferior portion of the implant and be appropriately sized to allow for bone ingrowth (SeeFIG. 18 ). - c. Shorter layers can be stacked with larger layers to create an overall taper as in
FIG. 19 . - d. Layers of varying lengths can be sacked to create a stepped taper as in
FIG. 20 . - e. Similar to the technique in (d), layers of varying length can be stacked. A smooth taper can be created by using layers that are tapered prior to stacking or the smooth taper can be created, by such ways as machining or hot forming, after the layers are stacked. The second of these would involve first creating a part like that in (d), then removing material to create the smooth taper shown in
FIG. 21 . - f. Another way of creating a smooth surface on a stepped taper is to have one or more outer layers which are parallel to the taper face, as shown in
FIG. 22 . - g. The design in (f) does not allow for a large amount of contact area between the outer layer of the taper and the corners of the stepped layer. One way of providing increased contact area (which can provide increased strength) is to taper the stepped layers as in
FIG. 21 before adding the outer layer(s) that are parallel to the face of the taper. An example of this is shown inFIG. 23 .
E. Interface with Bone
- a. If the design includes a reservoir, the reservoir itself can be tapered. The porous ingrowth layers can be of uniform thickness and layered outside of the reservoir (as indicated in
It is often desirable to have an implant-bone interface with relative high friction. Traditionally, this is achieved by such ways as a roughened implant surface, teeth (See
In a laminate implant, there are several options for creating such features. These options include the following:
-
- a. Form features prior to bonding laminate sheets: Form teeth or other “rough” features into the outermost layers of the implant prior to bonding them to the other sheets. These teeth can be created by several ways:
- i. Form material—for example: heat forming, cold forming.
- ii. Remove material—for example: machining, laser cutting, chemical etching.
- iii. Add material—attach material to create the features by, for example, insert molding, mechanical attachment, adhesive bonding, laser welding, solvent bonding.
- b. Form features after bonding laminate sheets: Form the rough surface features on the faces of the implant after the sheets have been bonded. These features can be formed by the same ways as listed in (a).
- c. Secondary feature (such as hooks, spikes, etc) protruding from the implant into the bone. This feature can be attached by, for example, insert molding, mechanical attachment, adhesive bonding, laser welding, or solvent bonding.
- a. Form features prior to bonding laminate sheets: Form teeth or other “rough” features into the outermost layers of the implant prior to bonding them to the other sheets. These teeth can be created by several ways:
F. Interface with Instruments
To aid in insertion of the implant into position in the body, it is often necessary to attach the implant to instrumentation. The material near the interface of the instrument and implant can often see additional stress. In a partially or fully laminate implant, it may be necessary to provide additional support in the region of this interface. This can be achieved by a number of ways, including: designing the instrument to reduce stresses and/or strengthening the implant in the region of the interface. For example, in the case of an instrument that contains a male thread which mates with a female thread in the implant, the implant can be strengthened by adding metal, solid polymer, or reinforced polymer in the region of the female thread. In machine design, thread inserts are frequently used to repair damaged threads. In this case, thread inserts can be used to strengthen the implant at the interface with the instrument(s).
G. Radiopaque Markers
When a radiolucent material, such as unfilled PEEK, is used, it is sometimes desirable to have the ability to see some or all of that implant on a diagnostic tool such as x-ray without the white-out problems of solid metal. For example, the surgeon may use such markers to determine the orientation and position of the implant to ensure proper placement during surgery. Radiopaque markers can provide this ability. The opacity and/or amount of radiopaque material can be controlled so that the marker does not prevent evaluation of the tissue near the implant by x-ray or other diagnostic ways. Material options include, but are not limited to, the following:
-
- a. Implantable metals (stainless steel, titanium, or titanium alloys for example).
- b. Barium sulfate filled PEEK.
- c. Carbon filled PEEK.
- d. Other polymers with radiopaque material (such as barium sulfate or zirconium dioxide).
Examples of the marker design include one or more of the following:
-
- a. One or more radiopaque pins.
- b. Assembly features such as rivets or pins.
- c. Coating a portion of the device with a radiopaque material. Examples of methods for creating a radiopaque coating include, but are not limited to, the following:
- i. Using chemical vapor deposition to deposit a layer of titanium onto the polymer.
- ii. Using a radiopaque ink such as Radiopaque™ ink (developed by CI Medical).
- d. One or more of the laminate layers being radiopaque. Examples of methods to make the layer(s) radiopaque include, but are not limited to, the following:
- i. Making the layer from an implantable metal (such as tantalum, titanium, titanium alloy, cobalt chrome, or stainless steel).
- ii. Using a barium sulfate filled polymer to create the layer.
- iii. Coating the layer with a radiopaque material—for example, using chemical vapor deposition to deposit a layer of titanium onto the surface of one or more layers.
- e. A slightly radiopaque porous material. This can be achieved, for example, by using a polymer with barium sulfate.
II. Porous Polymer Spinal Fusion Devices
The key to the success of a spinal fusion surgery is the formation of good bone growth between the vertebrae that are being fused. Evaluation of this bone growth is, thus, critical to determining the progress and eventual success of the surgery.
Existing porous spinal cages are made of biocompatible metals. Due to the density of these metals, the implants made post-operative examination of the tissue surrounding the implant difficult.
Several current devices are now made from solid biocompatible polymers such as PEEK. PEEK is a relatively radiolucent material. While this addresses the issue of radiopacity for solid fusion devices, it is often desired to encourage more rapid bone growth between the two vertebrae.
One solution for this problem is implants made from porous biocompatible polymers, such as PEEK or reinforced porous PEEK.
A. Overall Design
Such implants can be entirely porous or have a mix of porous and solid polymer. For example, a solid ring of material can surround a porous core (See
One embodiment of the design is a porous center component that mates with existing solid, ring-like devices. This device could be assembled with the solid device in a manufacturing setting or in the operating room.
If a solid region/component exists, the porous and solid regions may need, but do not necessarily need, to be attached to one another. Examples of methods that can be used to attach the porous and solid material are:
-
- a. Mechanical features—snap-fit connections, ‘dove-tail’ types of connections.
- b. Adhesive bonding.
- c. Solvent bonding.
- d. Heat applied by, for example, laser, ultrasonic or vibratory welding, convection heating, heat staking.
B. Material - a. Method of creating porosity
- i. Laminate design—bonding sheets of material which contain holes.
- ii. Foaming methods.
- iii. Bond ‘beads’ of polymer—bead of any shape can be bonded together (via, for example, heating, adhesive bonding, or solvent bonding) to create a porous structure.
- iv. Mix of polymer and dissolvable material.
- 1. One method involves creating a mixture of powdered implantable material (e.g. PEEK) and a powder (e.g. salt) that is soluble in something in which the implantable material is not soluble (such as water, isopropyl alcohol for the PEEK example). The mixture is then heated to bond the implantable particles together. Pressure can also be applied to aid in the bonding of particle to particle. Heat can be created by convection or other ways (such as coating the powder with a material that absorbs a given range of energy waves—such as laser waves—and causes heating. E.g. Clearweld coating by Gentex® Corporation). Finally, dissolve away the filler to create the porous implantable material. This method can create net shape parts or raw material shapes from which individual parts can be created.
- 2. Another method involves mixing an implantable polymer with a dissolvable material such as described above. The mixture is then pelletized and then injection molded to an intermediary or the final part shape. The filler is dissolved away to create the porous implantable polymer.
- b. Reinforcement—If improved mechanical properties are desired, various reinforcing materials can be used. For example, carbon fiber or barium sulfate can be used.
C. Radiopaque Markers
It is sometimes desirable to have the ability to see some of the implant on a diagnostic tool such as an x-ray without the white-out problems of solid metal. For example, the surgeon may use such markers to determine the orientation and position of the implant to ensure proper placement during surgery. Radiopaque markers can provide this ability. The opacity and/or amount of radiopaque material can be controlled so that the marker does not prevent evaluation of the tissue near the implant by x-ray or other diagnostic ways. Material options include, but are not limited to, the following:
-
- a. Implantable metals (stainless steel, titanium, or titanium alloys for example).
- b. Barium sulfate filled PEEK.
- c. Carbon filled PEEK.
- d. Other polymers with radiopaque material (such as barium sulfate or zirconium dioxide).
Examples of the marker design include one or more of the following: - a. One or more radiopaque pins.
- b. Coating a portion of the device with a radiopaque material. Examples of methods for creating a radiopaque coating include, but are not limited to, the following:
- i. Using chemical vapor deposition to deposit a layer of titanium onto the polymer.
- ii. Using a radiopaque ink such as Radiopaque™ ink (developed by CI Medical).
- c. A slightly radiopaque porous material. This can be achieved, for example, by using a polymer with barium sulfate.
Referring now to
A cavity 108 is formed in the implant body 102 extending through the first surface 104 and second surface 106 to form a continuous cavity 108 through the implant body 102. The cavity 108 has a first cavity entrance 110 formed through the first surface 104 and a second cavity entrance 112 (shown in
A load bearing member 114 comprising a substantially porous material having a first contact surface 116 is held within the cavity 108 that is formed within the implant body 102. As used herein, “substantially porous” indicates a porosity of at least 20%, but can be significantly higher. For example, the load bearing member 114 can have a total volume, that is the entire volume occupied by the load bearing member 114, of which 60% or more is defined by pores 117 formed in the load bearing member 114. In other words, 40% of the total volume of the load bearing member 114 can be occupied by structural material forming the load bearing member 114 while 60% of the total volume is occupied by empty spaced defined by the pores 117, in aggregate. If an extremely porous material is used to form the load bearing member 114, the pores 117, in aggregate, can occupy 80% or more of the total volume of the load bearing member 114. If desired, one or more therapeutic agents can be held within some or all of the pores 117 for elution into surrounding anatomic features after implantation of the orthopaedic implant 100 to increase the efficacy of the surgical procedure. A non-exhaustive list of possible therapeutic agents that can be provided in the pores 117 includes various growth factors, bone morphogenetic factors, bone morphogenetic proteins, anti-microbial agents, anti-inflammatories, anti-coagulants, painkillers, cytotoxic substances, stem cells, and any other substance, known or unknown, that is desirable to elute from the orthopaedic implant 100 following implantation. The material(s) used to form the load bearing member 114 should, like the implant body 102, be biocompatible so that the orthopaedic implant 100 is suitable for implantation at an anatomical site within a patient. It is also useful if the load bearing member 114 is formed from one or more materials that are non-resorbable, i.e., the material of the load bearing member 114 can maintain at least 90% of its original mass after being implanted in a living patient for at least a year. Examples of such materials are PEEK, tantalum, and titanium, but other porous materials are also contemplated as being used. The load bearing member 114 can comprise either a synthetic material, such as those previously described, or one or more naturally derived materials, such as a bone graft. The naturally derived material can also be, for example, cells or tissues harvested from the patient or a different organism, scaffolds created using collagen or other biomaterials, etc. It is useful, but not required, for the load bearing member 114 to substantially fill the cavity 108 so that at least 90% of the empty space in the implant body 102 defined by the cavity 108 is filled by the bearing member 114. Such filling of the cavity 108 by the load bearing member 114 makes it easier to hold the load bearing member 114 within the cavity 108 during implantation.
The first surface 104 defines a first peak 118, which is a point on the first surface 104 that has a maximum height, relative to a ground surface, when the second surface 106 of the implant body 102 is laid on the ground surface. The first peak 118 of implant body 102 is best shown in
Due to the varying shapes of anatomic structures and desired load bearing characteristics, the first contact surface 116 can be a curved surface or a planar surface. The relative sizing between the first surface 104 and the first contact surface 116 can also be adjusted, as desired, to balance the load bearing characteristics of the load bearing member 114. As can be seen, the first contact surface 116 defines a contact surface area and the first surface 104 defines a first surface area, with the contact surface area and first surface area together defining a top surface area of the orthopaedic implant 100. The relative percentage of the top surface area that the contact surface area makes up can be altered to give varying amount of contact surface for anatomic structures during implantation. It is contemplated that the contact surface area can be 40 to 90% of the total surface area when a large contact surface 116 is desired, or less than 40% of the total surface area when a smaller contact surface 116 is desired. It should be understood that the term “top surface area” is used for convenience of description only and not to limit the scope of the present invention.
Optionally, the load bearing member 114 can have a second contact surface 120 extending out of the cavity 108 past the second cavity entrance 112 so that it extends past a second peak 122 of the second surface 106 of the implant body 102. The second peak 122 of the second surface 106 is analogous to the first peak 118 of the first surface 104, with the key difference being that the second peak 122 defines a maximum height of the second surface 106 relative to a ground surface when the first surface 104 is laid on the ground surface. The second contact surface 120 can be configured and altered similarly to the first contact surface 116 so that the second contact surface 120 can be in contact with an anatomic structure following implantation. The second contact surface 120 can be a mirror image of the first contact surface 116 or a different configuration, depending on the desired load bearing characteristics of the load bearing member 114 caused by loads bearing on the first and second contact surfaces 116, 120 from surrounding anatomic structures. It can be useful if the pores 117 of the load bearing member 114 interconnect from the first contact surface 116 to the second contact surface 120 so that a travel path through the entirety of the load bearing member 114 can be formed through interconnected pores 117 formed therein.
To assist in implanting the orthopaedic implant 100, an opening 124 can be formed through another surface 126 of the implant body 102 to the cavity 108. The opening 124 can be any size or shape that allows for an insertion tool (not shown) to be placed within the opening 124 to help steady and position the orthopaedic implant 100 during implantation. The load bearing member 114 can partially extend into the opening 124, another material can be held in the opening 124, or the opening 124 can provide a clear path to the load bearing member 114 held in the cavity 108. In a similar manner, one or more protrusions 128 can be placed adjacent to the opening 124 that are shaped to interact with the insertion tool and provide a more stable connection between the orthopaedic implant 100 and the insertion tool. The opening 124 and protrusion(s) 128 can also be configured so that a removal tool (not shown), rather than an insertion tool, can interact with the opening 124 and protrusion(s) 128 to remove the orthopaedic implant 100 from a patient following implantation, if necessary.
Referring now to
As shown in
Referring now to
Referring now to
Referring now to
A load bearing member 410 comprising a substantially porous material is held within the cavity 408. The load bearing member 410 has a first contact surface 412 that extends out of the cavity 408 and is proud of a portion of the first surface 404 to which the first contact surface 412 is immediately adjacent. Put another way, the first contact surface 412 outwardly projects from the cavity 408 so that it will contact surrounding anatomic features when the orthopaedic implant 400 is implanted and isolate portions of the first surface 404 immediately adjacent to the cavity 408 from initially bearing load from the surrounding anatomic features. Since the first surface 404 is sloped, the first contact surface 412 does not necessarily extend past a peak of the first surface 404, as previously described first contact surfaces do. However, in all other aspects, load bearing member 410 and first contact surface 412 can be configured similarly to previously described load bearing members and contact surfaces.
Referring now to
Referring now to
A cavity 508 is formed in the implant body 502 extending through the first surface 504 and second surface 506 to form a continuous cavity 508 through the implant body 502. The cavity 508 has a first cavity entrance 510 formed through the first surface 504 and a second cavity entrance 512 (
A load bearing member 514 comprising a substantially porous material having a first contact surface 516 and having pores 517 is held within the cavity 508 that is formed within the implant body 502. The load bearing member 514 and its contact surface 516 can be configured similarly to previously described load bearing members 114, 214 and 410 and their respective contact surfaces 116, 216, and 412.
Preferably, and as illustrated, the first contact surface 516 of the load bearing member 514 extends out of the cavity 508 past the first cavity entrance 510 so that the first contact surface 516 extends past the first surface 504. In this sense, the first contact surface 516 defines a thickness T4 that extends past and projects from the first surface 504, which can be either constant or varying throughout the first contact surface 516. However, in another embodiment, the thickness T4 has a constant value of zero, thus the first contact surface 516 is flush with the first surface 504. By extending the first contact surface 516 past the first surface 504, the first contact surface 516 can be placed in contact with an anatomic structure, such as a vertebra, during implantation while isolating the first surface 504 from contact with the anatomic structure. Once implanted, the porous load bearing member 514 can then bear load from the anatomic structure while allowing for ingrowth of tissue into the load bearing member 514 through the pores 517.
One or more first openings 524 can be formed through another surface 526 of the implant body 502 to the cavity 508. The load bearing member 514 can partially extend into the first openings 524, another material can be held in the first openings 524, or the first openings 524 can provide a clear path to the load bearing member 514 held in the cavity 508. The first openings 524 can be any size or shape that allows for an insertion/delivery tool, to be described more fully below, to be placed within a first opening 524 (e.g., coupled to the first opening 524) for delivery of a material agent to the load bearing member 514 via the first opening 524 during a surgical procedure for implanting the orthopaedic implant 500. Preferably, the first openings 524 are circular openings having a threaded outer portion 530 with a diameter d1, however the scope of the present invention covers first openings 524 having one or more different diameters or different geometric shapes with associated geometric parameters (e.g., parameters describing ellipses, squares, rectangles), and may have outer portions 530 that are not threaded.
Additionally, one or more second openings 528 can be placed adjacent to the first openings 524, shaped to interact with the insertion/delivery tool (described below) for providing a more stable connection between the orthopaedic implant 500 and the insertion/delivery tool for delivery of the material agent to the load bearing member 514 via the first opening 524 and/or for positioning the orthopaedic implant 500 during implantation. The first openings 524 and the second openings 528 can also be configured so that the insertion/delivery tool can interact with the first opening 524 and the second openings 528 to charge the load bearing member 514 with a material agent (described more fully below), or to recharge the load bearing member 514 during a second surgical procedure, if necessary.
The orthopaedic implant 500 includes plugs 532 that are coupled to the first openings 524. The plugs 532 prevent the material agent of the load bearing member 514, particularly after the load bearing member 514 has been charged with the material agent from the insertion/delivery tool via the first openings 524, from flowing out of the load bearing member 514 via the first openings 524 once the insertion/delivery tool has finished charging the load bearing member 514 and/or has been de-coupled from the first openings 524.
In another embodiment, the cavity 508 may optionally be divided into two or more sub-cavities. By way of an exemplary embodiment, the cavity 508 may optionally be divided into two sub-cavities 508A and 508B by a divider 509, formed from the same substantially non-porous material of the implant body 502. The load bearing member 514 may include porous material of different porosities held within the two sub-cavities 508A and 508B. In one embodiment, one or more first openings 524 are formed through the third surface 526 to each of the sub-cavities 508A and 508B.
As illustrated, the second contact surface 520 defines a thickness T5 that extends past and projects from the second surface 506, which can be either constant or varying throughout the second contact surface 506. However, in another embodiment, the thickness T5 has a constant value of zero, thus the second contact surface 520 is flush with the second surface 506.
The ID tool 600 includes an inserter 602, a cannula 604 (i.e., a tube), and a plunger 606. In one embodiment, the inserter 602 includes a tubular portion 608, an attachment portion 610 positioned at a first end 611 of the tubular portion 608, and a handle portion 612 positioned around a second end 613 of the tubular portion 608. The attachment portion 610 may include one or more pins 614 configured to engage with (also referred to as couple with or interact with) the one or more second openings 528 for enabling the inserter 602 to insert and/or position the orthopaedic implant 500 during implant, and/or stabilize the orthopaedic implant 500 for delivery of a material agent 619 to the orthopaedic implant 500 via the first openings 524, as will be described shortly. In addition, the attachment portion 610, including the one or more pins 614 engaged with the one or more second openings 528, in combination with the tubular portion 608, provides a means for guiding the cannula 604 to the first opening 524 and stabilizing the orthopaedic implant 500 when the cannula 604 is for coupled to the first opening 524.
The cannula 604 includes a tubular passage 605 having an attachment portion 616 configured to be coupled to the orthopaedic implant 500. In one embodiment, the attachment portion 616 is threaded. The threaded attachment portion 616 is configured to thread with the outer threaded portion 530 of the first opening 524. However, the scope of the invention covers the attachment portion 616 being non-threaded, having instead other means of attachment for attaching to the outer portion 530 of the first opening 524. The cannula 604 also includes a receiving end 618 configured to receive the material agent 619 and the plug 532 coupled to a the plunger 606. The receiving end 618 may also be configured to receive a rotatable means (not shown) for rotating the cannula 604 for threading the threaded attachment end 616 with the threaded outer portion 530 of the first opening 524 for securely, but removably, coupling the cannula 604 to the orthopaedic implant body 500 (e.g., to the first opening 524). As illustrated, the inserter 602 and the cannula 604 are configured such that the cannula 604 may be positioned in the tubular portion 608 of the inserter 602 (i.e., slid inside the tubular portion 608 of the inserter 602) for coupling the cannula 604 to the orthopaedic implant 500 via the threaded outer portion 530 of the first opening 524.
The insertion/delivery tool 600 also comprises the plunger 606. The plunger 606 includes a first end 620 and a handle end 622, connected to each other via a rod 624. The first end 620 is configured to couple with the distal portion 538 of the plug 532 for pushing the plug 532, and the material agent 619 residing in the cannula 604 between the plug 532 and the attachment end 616, through the cannula 604 towards the first opening 524. In one embodiment, the first end 620 is a hexagon-shaped socket configured to couple with a hexagon-shaped distal end 542 of the plug 532. Once the first end 620 of the plunger 606 is coupled with the distal end 542 of the plug 532, a force may be applied to the handle end 622 for pushing the plug 532 (and any material agent 619 residing in the cannula 604 between the plug 532 and the attachment end 616) through the cannula 604, thereby forcing the material agent 619 into the load bearing member 514 via the first opening 524, and once the threaded proximal portion 536 of the plug 532 is pushed up against the threaded inner portion 534 of the first opening 524, the handle end 622 may be rotated for threading the plug 532 into the threaded inner portion 534 of the first opening 524, thereby sealing the first opening 524 against expulsion or leakage of the material agent 619 from the load bearing member 514. In one embodiment, the plunger 606 comprises one or more sealing rings 624, such as O-rings, positioned around the rod 624 for preventing leakage of the material agent 619 into a portion of the cannula 604 between the sealing ring 624 and the receiving end 618 of the cannula 604 as the plunger 606 is being pushed down the cannula 604 in the direction of the first opening 524.
In one embodiment, and as illustrated, the tubular passage 605 has a tubular passage diameter dp, and the middle diameter dm of the plug 532 is equal to the tubular passage diameter dp and the distal diameter dd of the plug 532 is less than the tubular passage diameter dp.
In another embodiment, the inserter 602 and the cannula 604 positioned within the tubular portion 608 of the inserter 602 may collectively be referred to as a tubular assembly 603 having the tubular passage 605. The tubular assembly also includes a first end 607 configured to couple (i.e., attach) to the orthopaedic implant 500 and a second end 609 configured to receive the material agent 619, the plug 532 and the plunger 606.
In step 628, the inserter 602 is coupled to the orthopaedic implant 500. In one embodiment, the one or more pins 614 of the attachment portion 610 of the inserter 602 is coupled to the one or more second openings 528 of the orthopaedic implant 500. In one embodiment, the two second openings 528 are formed in the surface 526, also referred to as a side surface of the orthopaedic implant. The surface 526 is formed between the first surface 504 and the second surface 506 of the orthopaedic implant 500. In an embodiment, the two second openings are formed to straddle the first opening 524 in the surface 526.
In step 630, the cannula 604 is coupled to the orthopaedic implant 500. In one embodiment, the attachment portion 616 of the cannula 604 is slid into the inserter 602 until the attachment portion 616 reaches the outer portion 530 of the first opening 524. The cannula 604 is then rotated, preferably via use of a rotating means, such as a socket, wrench, etc., applied to the receiving end 618 of the cannula 604, causing the attachment portion 616 to rotate, thereby coupling the attachment portion 616 to the outer portion 530 of the first opening 524. In one embodiment, the both the attachment portion 616 and the outer portion 530 are threaded, and the rotation of the cannula 604 causes the threaded attachment portion 616 to thread with the threaded outer portion 530, thereby coupling the cannula 604 to the orthopaedic implant 500, or according to one embodiment, to the first opening 524 of the orthopaedic implant 500.
In step 632, the material agent 619 is placed into the cannula 604 via the receiving end 618. In one embodiment, the material agent is a flowable material. The scope of the present invention covers flowable materials, such as bone pastes, bone putties, bone grafts, or therapeutics, for example, antibiotics, blood plasmas, bone marrow, pain medications, or drugs, such as tumor-fighting drugs, all having conventional viscosities known to those of skill in the art. Furthermore, the scope of the present invention covers any biological material agents that may be embodied as a flowable material. In addition, the scope of the present invention covers material agents having a range of viscosities, which in combination with a porous load bearing member 514 having various interconnectivities and pore sizes, are deliverable into the porous load bearing member 514 via the first opening 524, the cannula 604 and the plunger 606.
In step 634, the first end 620 of the plunger 606 coupled to the plug 532 is inserted into and pushed through the cannula 604 in the direction of the first opening 524, thereby enabling the plug 532 to push the material agent 619 in the direction of the first opening 524 and forcing the material agent 619 through the first opening 524 for charging the porous load bearing member 514 of the orthopaedic implant 500 with the material agent 619. In one embodiment, the first end 620 of the plunger 606 is removeably-coupled to the distal end 542 of the plug 532, via for example, a socket. In another embodiment, the first end 620 of the plunger 606 is breakably-coupled to the distal end 542 of the plug 532 at a joint 626 between the distal portion 542 and the first end 620.
In step 636, after the plunger 606 coupled to the plug 532 has pushed the proximal portion 536 of the plug 532 adjacent to the inner portion 534 of the first opening 524, the plunger 606 is rotated within the cannula 604, causing the plug 532 to couple (also referred to as attach or fasten) with the first opening 524, thereby sealing the first opening 524. In one embodiment, both the proximal portion 536 of the plug 532 and the inner portion 534 of the first opening 524 are threaded, and the rotation of the cannula 604 causes the proximal portion 536 to thread with the inner portion 534, thereby sealing the first opening 524 against expulsion (also referred to as leakage) of the material agent 619 of the load bearing member 514 through the first opening 524.
In step 638, if the first end 620 of the plunger 606 is removably-coupled to the distal end 542 of the plug 532, then after the plug 532 is threaded into the first opening 524 in step 636, the first end 620 of the plunger 606 is decoupled from the distal end 542 and the plunger 606 may be removed from the cannula 604. If the first end 620 of the plunger 606 is breakably-coupled to the distal end 542 of the plug 532 at the joint 626, then after the plug 532 is threaded into the first opening 524 in step 636, further rotation of the plunger 606 causes the first end 620 to break with the distal end 542 of the plug 532 along the joint 626. The plunger 606 may then be removed from the cannula 604.
In step 640, the cannula 604 is rotated within the inserter 602 in the opposite direction as in step 630, thereby de-coupling the cannula 602 from the orthopaedic implant 500. For example, rotating the cannula 604 in the opposite direction unthreads the threaded attachment end 616 of the cannula 604 from the threaded outer portion 530 of the first opening 524, thereby allowing the cannula 604 to be slid out of the tubular portion 608 of the inserter 602.
In step 642, the inserter 602 is de-coupled from the orthopaedic implant 500. In one embodiment, the one or more pins 614 of the attachment portion 610 of the inserter 602 is de-coupled from the one or more second openings 528 of the orthopaedic implant 500.
While this invention has been described with respect to at least one embodiment, the present invention can be further modified within the spirit and scope of this disclosure. This application is therefore intended to cover any variations, uses, or adaptations of the invention using its general principles. Further, this application is intended to cover such departures from the present disclosure as come within known or customary practice in the art to which this invention pertains and which fall within the limits of the appended claims.
Claims
1. An orthopaedic implant, comprising:
- an implant body having a first surface, a second surface opposite said first surface, and a cavity formed therein that extends through said first surface and said second surface, said implant body being substantially non-porous, said implant body further including a third surface with at least one first opening formed therethrough to said cavity, said at least one first opening comprising an outer portion having an outer diameter and an inner portion having an inner diameter, said outer diameter greater than said inner diameter;
- a load bearing member comprising a substantially porous material held within said cavity, said substantially porous material having a material agent held therein, said load bearing member having a first contact surface extending out of said cavity past said first surface,
- wherein said outer portion of said at least one first opening is configured to couple to a tool for receiving, from the tool, said material agent; and
- a plug coupled to said inner portion of said at least one first opening and sealing said at least one first opening for preventing said material agent from exiting said substantially porous material via said at least one first opening, wherein said inner portion of said at least one first opening comprises a threaded inner portion, said plug comprises a threaded proximal portion threaded with said threaded inner portion of said at least one first opening and a distal portion having a diameter less than said outer diameter of said outer portion of said at least one first opening, said outer portion comprising a threaded outer portion, wherein said plug comprises a middle portion, said middle portion having a diameter greater than said inner diameter of said threaded inner portion of said at least one first opening and less than said outer diameter of said threaded outer portion of said at least one first opening.
2. The orthopaedic implant according to claim 1, wherein said load bearing member has a second contact surface opposite said first contact surface, said load bearing member having interconnecting pores extending from said first contact surface to said second contact surface, said load bearing member having a total volume and said interconnecting pores in aggregate occupying at least 60% of said total volume.
3. The orthopaedic implant according to claim 1, wherein said cavity comprises at least two sub-cavities, wherein said at least one first opening comprises at least two first openings, and wherein said substantially porous material held within said at least two sub-cavities has different porosities.
4. The orthopaedic implant according to claim 1, wherein said material agent is a flowable material.
5. The orthopaedic implant according to claim 4, wherein said flowable material is a bone graft.
6. The orthopaedic implant according to claim 4, wherein said flowable material is a bone putty.
7. The orthopaedic implant according to claim 4, wherein said flowable material is a therapeutic.
8. The orthopaedic implant according to claim 1, wherein said distal portion has a distal end, said distal end shaped for receiving a rotating means for unthreading said plug from said at least one first opening.
9. The orthopaedic implant according to claim 8, wherein said distal end is shaped as a hexagon.
10. The orthopaedic implant according to claim 1, wherein said inner portion of said at least one first opening is configured to couple to said plug received from said tool.
11. The orthopaedic implant according to claim 1, wherein said third surface comprises a least one second opening configured to couple with said tool.
12. The orthopaedic implant according to claim 1, wherein said distal end of said plug extends out of said inner portion of said at least one first opening when said threaded proximal portion is fully advanced in said at least one first opening.
3662405 | May 1972 | Bartz et al. |
3683421 | August 1972 | Martinie |
3855638 | December 1974 | Pilliar |
3867728 | February 1975 | Stubstad et al. |
4011602 | March 15, 1977 | Rybicki et al. |
4060081 | November 29, 1977 | Yannas et al. |
4156943 | June 5, 1979 | Collier |
4222128 | September 16, 1980 | Tomonaga et al. |
4450150 | May 22, 1984 | Sidman |
4453537 | June 12, 1984 | Spitzer |
4485097 | November 27, 1984 | Bell |
4520821 | June 4, 1985 | Schmidt et al. |
4608052 | August 26, 1986 | Van Kampen et al. |
4609551 | September 2, 1986 | Caplan et al. |
4620327 | November 4, 1986 | Caplan et al. |
4644627 | February 24, 1987 | Palazzo |
4660755 | April 28, 1987 | Farling et al. |
4737411 | April 12, 1988 | Graves, Jr. et al. |
4769041 | September 6, 1988 | Morscher |
4846834 | July 11, 1989 | Von Recum et al. |
4858603 | August 22, 1989 | Clemow |
4936859 | June 26, 1990 | Morscher et al. |
4976738 | December 11, 1990 | Frey et al. |
5030233 | July 9, 1991 | Ducheyne |
5041107 | August 20, 1991 | Heil, Jr. |
5084051 | January 28, 1992 | Tormala et al. |
5092898 | March 3, 1992 | Bekki et al. |
5100392 | March 31, 1992 | Orth et al. |
5104410 | April 14, 1992 | Chowdhary |
5190550 | March 2, 1993 | Miller et al. |
5197985 | March 30, 1993 | Caplan et al. |
5204055 | April 20, 1993 | Sachs et al. |
5219363 | June 15, 1993 | Crowninshield et al. |
5226914 | July 13, 1993 | Caplan et al. |
5281210 | January 25, 1994 | Burke et al. |
5282861 | February 1, 1994 | Kaplan |
5306309 | April 26, 1994 | Wagner et al. |
5328765 | July 12, 1994 | Anderson et al. |
5370690 | December 6, 1994 | Barrett |
5380328 | January 10, 1995 | Morgan |
5443471 | August 22, 1995 | Swajger |
5458643 | October 17, 1995 | Oka et al. |
5462362 | October 31, 1995 | Yuhta et al. |
5490962 | February 13, 1996 | Cima et al. |
5496372 | March 5, 1996 | Hamamoto et al. |
5514182 | May 7, 1996 | Shea |
5518680 | May 21, 1996 | Cima et al. |
5531750 | July 2, 1996 | Even-Esh |
5534028 | July 9, 1996 | Bao et al. |
5537851 | July 23, 1996 | Sheu et al. |
5549700 | August 27, 1996 | Graham |
5571187 | November 5, 1996 | Devanathan |
5593443 | January 14, 1997 | Carter et al. |
5637175 | June 10, 1997 | Feygin et al. |
5641323 | June 24, 1997 | Caldarise |
5702449 | December 30, 1997 | McKay |
5730817 | March 24, 1998 | Feygin et al. |
5732469 | March 31, 1998 | Hamamoto et al. |
5750103 | May 12, 1998 | Cherksey |
5769897 | June 23, 1998 | Harle |
5776199 | July 7, 1998 | Michelson |
5800828 | September 1, 1998 | Dionne et al. |
5807406 | September 15, 1998 | Brauker et al. |
5848989 | December 15, 1998 | Villani |
5849015 | December 15, 1998 | Haywood et al. |
5869170 | February 9, 1999 | Cima et al. |
5871484 | February 16, 1999 | Spievack et al. |
5876550 | March 2, 1999 | Feygin et al. |
5879406 | March 9, 1999 | Lilley |
5916269 | June 29, 1999 | Serbousek et al. |
5971985 | October 26, 1999 | Carchidi et al. |
5989250 | November 23, 1999 | Wagner et al. |
6010336 | January 4, 2000 | Shimotoso et al. |
6037519 | March 14, 2000 | McKay |
6045581 | April 4, 2000 | Burkinshaw |
6110179 | August 29, 2000 | Flivik et al. |
6136029 | October 24, 2000 | Johnson et al. |
6136031 | October 24, 2000 | Middleton |
6139574 | October 31, 2000 | Vacanti et al. |
6143035 | November 7, 2000 | McDowell |
6159247 | December 12, 2000 | Klawitter et al. |
6176874 | January 23, 2001 | Vacanti et al. |
6200347 | March 13, 2001 | Anderson et al. |
6238435 | May 29, 2001 | Meulink et al. |
6283997 | September 4, 2001 | Garg et al. |
6290726 | September 18, 2001 | Pope et al. |
6306424 | October 23, 2001 | Vyakamam et al. |
6315797 | November 13, 2001 | Middleton |
6322564 | November 27, 2001 | Surma |
6328765 | December 11, 2001 | Hardwick et al. |
6333029 | December 25, 2001 | Vyakamam et al. |
6337198 | January 8, 2002 | Levene et al. |
6365149 | April 2, 2002 | Vyakamam et al. |
6379385 | April 30, 2002 | Kalas et al. |
6379391 | April 30, 2002 | Masini |
6395011 | May 28, 2002 | Johanson et al. |
6409764 | June 25, 2002 | White et al. |
6419704 | July 16, 2002 | Ferree |
6423095 | July 23, 2002 | Van Hoeck et al. |
6423252 | July 23, 2002 | Chun et al. |
6425921 | July 30, 2002 | Grundei et al. |
6440734 | August 27, 2002 | Pykett et al. |
6454811 | September 24, 2002 | Sherwood et al. |
6458162 | October 1, 2002 | Koblish et al. |
6461385 | October 8, 2002 | Gayer et al. |
6471689 | October 29, 2002 | Joseph et al. |
6471993 | October 29, 2002 | Shastri et al. |
6475137 | November 5, 2002 | Elist |
6494916 | December 17, 2002 | Babalola et al. |
6514514 | February 4, 2003 | Atkinson et al. |
6520993 | February 18, 2003 | James et al. |
6526984 | March 4, 2003 | Nilsson et al. |
6527810 | March 4, 2003 | Johnson et al. |
6530958 | March 11, 2003 | Cima et al. |
6533818 | March 18, 2003 | Weber et al. |
6534084 | March 18, 2003 | Vyakamam et al. |
6544472 | April 8, 2003 | Compton et al. |
6547824 | April 15, 2003 | Price |
6551290 | April 22, 2003 | Elsbery et al. |
6554857 | April 29, 2003 | Zilla et al. |
6565572 | May 20, 2003 | Chappius |
6571130 | May 27, 2003 | Ljungstroem et al. |
6599322 | July 29, 2003 | Amrich et al. |
6610095 | August 26, 2003 | Pope et al. |
6626950 | September 30, 2003 | Brown et al. |
6635049 | October 21, 2003 | Robinson et al. |
6638310 | October 28, 2003 | Lin et al. |
6645251 | November 11, 2003 | Salehi et al. |
6656489 | December 2, 2003 | Mahmood et al. |
6660040 | December 9, 2003 | Chan et al. |
6673108 | January 6, 2004 | Zilla et al. |
6682567 | January 27, 2004 | Schroeder |
6692528 | February 17, 2004 | Ward et al. |
6709463 | March 23, 2004 | Pope et al. |
6709464 | March 23, 2004 | Scott |
6712850 | March 30, 2004 | Vyakamam et al. |
6723120 | April 20, 2004 | Yan |
6736850 | May 18, 2004 | Davis |
6749636 | June 15, 2004 | Michelson |
6758863 | July 6, 2004 | Estes et al. |
6783546 | August 31, 2004 | Zucherman et al. |
6818620 | November 16, 2004 | Bhatnagar |
6852272 | February 8, 2005 | Artz et al. |
6855167 | February 15, 2005 | Shimp et al. |
6863899 | March 8, 2005 | Koblish et al. |
6866685 | March 15, 2005 | Chan et al. |
6881413 | April 19, 2005 | Bartholeyns |
6893465 | May 17, 2005 | Huang |
6913623 | July 5, 2005 | Zhu |
6916321 | July 12, 2005 | TenHuisen et al. |
6958078 | October 25, 2005 | Goel et al. |
6969383 | November 29, 2005 | Hildebrand |
6979353 | December 27, 2005 | Bresina |
6989033 | January 24, 2006 | Schmidt |
6993406 | January 31, 2006 | Cesarano, III et al. |
7018416 | March 28, 2006 | Hanson et al. |
7018418 | March 28, 2006 | Amrich et al. |
7052710 | May 30, 2006 | Giordano et al. |
7077867 | July 18, 2006 | Pope et al. |
7087086 | August 8, 2006 | Li et al. |
7087200 | August 8, 2006 | Taboas et al. |
7090668 | August 15, 2006 | U et al. |
7094371 | August 22, 2006 | Lo |
7108828 | September 19, 2006 | Lefebvre et al. |
7112223 | September 26, 2006 | Davis |
7128762 | October 31, 2006 | Middleton |
D533277 | December 5, 2006 | Blain |
7174282 | February 6, 2007 | Hollister et al. |
7189409 | March 13, 2007 | Pirhonen et al. |
7192440 | March 20, 2007 | Andreas et al. |
D539934 | April 3, 2007 | Blain |
7208222 | April 24, 2007 | Rolfe et al. |
D541940 | May 1, 2007 | Blain |
7226612 | June 5, 2007 | Sohier et al. |
7238186 | July 3, 2007 | Zdeblick et al. |
7238363 | July 3, 2007 | Mansouri et al. |
7250055 | July 31, 2007 | Vanderwalle |
7250060 | July 31, 2007 | Trieu |
7255713 | August 14, 2007 | Malek |
7300439 | November 27, 2007 | May |
D564095 | March 11, 2008 | Blain |
D566276 | April 8, 2008 | Blain |
7354452 | April 8, 2008 | Foley |
7537617 | May 26, 2009 | Bindsell et al. |
7537664 | May 26, 2009 | O'Neill et al. |
D594986 | June 23, 2009 | Miles et al. |
D599019 | August 25, 2009 | Pimenta et al. |
7575572 | August 18, 2009 | Sweeney |
7632228 | December 15, 2009 | Brauker et al. |
7632338 | December 15, 2009 | Cipollini |
7666230 | February 23, 2010 | Orban et al. |
7674426 | March 9, 2010 | Grohowski, Jr. |
7674477 | March 9, 2010 | Schmid et al. |
D616546 | May 25, 2010 | Vraney et al. |
7717956 | May 18, 2010 | Lang |
D619719 | July 13, 2010 | Pannu |
D620114 | July 20, 2010 | Pannu |
D620115 | July 20, 2010 | Pannu |
D620116 | July 20, 2010 | Pannu |
D621509 | August 10, 2010 | Lovell |
D627467 | November 16, 2010 | Pannu |
D627468 | November 16, 2010 | Richter et al. |
7833271 | November 16, 2010 | Mitchell et al. |
7875080 | January 25, 2011 | Puno et al. |
7909870 | March 22, 2011 | Kraus |
7910124 | March 22, 2011 | Boyan et al. |
7963995 | June 21, 2011 | Richelsoph |
8062372 | November 22, 2011 | Tsuang et al. |
8066750 | November 29, 2011 | Oi et al. |
8147521 | April 3, 2012 | Cornwall et al. |
D671645 | November 27, 2012 | Curran et al. |
D674092 | January 8, 2013 | Lovell |
8496706 | July 30, 2013 | Ragab et al. |
8568482 | October 29, 2013 | Kraus et al. |
8623088 | January 7, 2014 | Tohmeh et al. |
8685099 | April 1, 2014 | Bhattacharya et al. |
D770045 | October 25, 2016 | Curran et al. |
20010038848 | November 8, 2001 | Donda et al. |
20010039455 | November 8, 2001 | Simon et al. |
20020022884 | February 21, 2002 | Mansmann |
20020029083 | March 7, 2002 | Zucherman et al. |
20020035400 | March 21, 2002 | Bryan et al. |
20020062154 | May 23, 2002 | Ayers |
20020072798 | June 13, 2002 | Riesle et al. |
20020091447 | July 11, 2002 | Shimp et al. |
20020106393 | August 8, 2002 | Bianchi et al. |
20020128715 | September 12, 2002 | Bryan et al. |
20020143402 | October 3, 2002 | Steinberg |
20020161447 | October 31, 2002 | Salehi et al. |
20020182241 | December 5, 2002 | Borenstein et al. |
20020183850 | December 5, 2002 | Felt et al. |
20020197178 | December 26, 2002 | Yan |
20030003127 | January 2, 2003 | Brown |
20030004578 | January 2, 2003 | Brown et al. |
20030006534 | January 9, 2003 | Taboas et al. |
20030012805 | January 16, 2003 | Chen et al. |
20030023311 | January 30, 2003 | Trieu |
20030055506 | March 20, 2003 | Stoy et al. |
20030060886 | March 27, 2003 | Van Hoeck et al. |
20030060891 | March 27, 2003 | Shah |
20030069465 | April 10, 2003 | Benkowski et al. |
20030097182 | May 22, 2003 | Buchman et al. |
20030105527 | June 5, 2003 | Bresina |
20030114934 | June 19, 2003 | Steinberg |
20030114936 | June 19, 2003 | Sherwood et al. |
20030118649 | June 26, 2003 | Gao et al. |
20030120344 | June 26, 2003 | Michelson |
20030125739 | July 3, 2003 | Bagga et al. |
20030130743 | July 10, 2003 | Scott |
20030139809 | July 24, 2003 | Worst et al. |
20030171738 | September 11, 2003 | Konieczynski et al. |
20030171820 | September 11, 2003 | Wilshaw et al. |
20030180171 | September 25, 2003 | Artz et al. |
20030187513 | October 2, 2003 | Durniak |
20030203002 | October 30, 2003 | Murphy et al. |
20030206928 | November 6, 2003 | Tormala et al. |
20030208274 | November 6, 2003 | Davis |
20040024470 | February 5, 2004 | Giordano et al. |
20040034357 | February 19, 2004 | Beane et al. |
20040034427 | February 19, 2004 | Goel et al. |
20040063206 | April 1, 2004 | Rowley et al. |
20040073197 | April 15, 2004 | Kim |
20040115172 | June 17, 2004 | Bianchi et al. |
20040126405 | July 1, 2004 | Sahatjian et al. |
20040147905 | July 29, 2004 | Krumme |
20040153165 | August 5, 2004 | Li et al. |
20040180072 | September 16, 2004 | Tunc et al. |
20040191106 | September 30, 2004 | O'Neill et al. |
20040191292 | September 30, 2004 | Chou |
20040193273 | September 30, 2004 | Huang |
20040199260 | October 7, 2004 | Pope et al. |
20040210274 | October 21, 2004 | Bauhahn et al. |
20040210316 | October 21, 2004 | King |
20040215173 | October 28, 2004 | Kunst |
20040225360 | November 11, 2004 | Malone |
20040249463 | December 9, 2004 | Bindseil et al. |
20040258732 | December 23, 2004 | Shikinami |
20040265350 | December 30, 2004 | Sambrook |
20040267263 | December 30, 2004 | May |
20050015059 | January 20, 2005 | Sweeney |
20050015150 | January 20, 2005 | Lee |
20050021084 | January 27, 2005 | Lu et al. |
20050042288 | February 24, 2005 | Koblish |
20050049715 | March 3, 2005 | Ito et al. |
20050049716 | March 3, 2005 | Wagener et al. |
20050055099 | March 10, 2005 | Ku |
20050058684 | March 17, 2005 | Shanley et al. |
20050059972 | March 17, 2005 | Biscup |
20050085888 | April 21, 2005 | Andreas et al. |
20050100470 | May 12, 2005 | Lefebvre et al. |
20050100578 | May 12, 2005 | Schmid et al. |
20050112397 | May 26, 2005 | Rolfe et al. |
20050119753 | June 2, 2005 | McGahan et al. |
20050125073 | June 9, 2005 | Orban et al. |
20050137707 | June 23, 2005 | Malek |
20050143822 | June 30, 2005 | Paul |
20050159819 | July 21, 2005 | McCormack et al. |
20050171611 | August 4, 2005 | Stoy et al. |
20050175703 | August 11, 2005 | Hunter et al. |
20050177238 | August 11, 2005 | Khandkar et al. |
20050177247 | August 11, 2005 | Canham et al. |
20050182494 | August 18, 2005 | Schmid |
20050187555 | August 25, 2005 | Biedermann et al. |
20050192669 | September 1, 2005 | Zdeblick et al. |
20050197654 | September 8, 2005 | Edman et al. |
20050202371 | September 15, 2005 | McGuire |
20050220837 | October 6, 2005 | Disegi et al. |
20050222688 | October 6, 2005 | Zilla et al. |
20050228503 | October 13, 2005 | Gundolf |
20050246032 | November 3, 2005 | Bokros et al. |
20050271694 | December 8, 2005 | Mansouri et al. |
20050272153 | December 8, 2005 | Xuenong et al. |
20050273082 | December 8, 2005 | Olsen |
20050273178 | December 8, 2005 | Boyan et al. |
20050288795 | December 29, 2005 | Bagga |
20060002810 | January 5, 2006 | Grohowski, Jr. |
20060015186 | January 19, 2006 | Isaac |
20060047341 | March 2, 2006 | Trieu |
20060057737 | March 16, 2006 | Santini, Jr. et al. |
20060064170 | March 23, 2006 | Smith et al. |
20060064172 | March 23, 2006 | Trieu |
20060083730 | April 20, 2006 | Kusanagi et al. |
20060093646 | May 4, 2006 | Cima et al. |
20060100706 | May 11, 2006 | Shadduck et al. |
20060100716 | May 11, 2006 | Lerf |
20060105015 | May 18, 2006 | Perla et al. |
20060111782 | May 25, 2006 | Petersen |
20060111785 | May 25, 2006 | O'Neil |
20060121609 | June 8, 2006 | Yannas et al. |
20060129242 | June 15, 2006 | Bergeron et al. |
20060141012 | June 29, 2006 | Gingras |
20060149220 | July 6, 2006 | Ullestad et al. |
20060149386 | July 6, 2006 | Clark et al. |
20060173542 | August 3, 2006 | Shikinami |
20060178744 | August 10, 2006 | de Villiers et al. |
20060193885 | August 31, 2006 | Leonard Neethling et al. |
20060195188 | August 31, 2006 | O'Driscoll et al. |
20060200166 | September 7, 2006 | Hanson et al. |
20060204581 | September 14, 2006 | Gower |
20060229715 | October 12, 2006 | Istephanous et al. |
20060235534 | October 19, 2006 | Gertzman et al. |
20060241593 | October 26, 2006 | Sherman et al. |
20060264950 | November 23, 2006 | Nelson et al. |
20060271022 | November 30, 2006 | Steinbach et al. |
20060271201 | November 30, 2006 | Kumar |
20060276900 | December 7, 2006 | Carpenter |
20060282166 | December 14, 2006 | Molz et al. |
20060287689 | December 21, 2006 | Debruyne et al. |
20060289388 | December 28, 2006 | Yang et al. |
20060293757 | December 28, 2006 | McKay et al. |
20070016163 | January 18, 2007 | Santini, Jr. et al. |
20070026069 | February 1, 2007 | Shastri et al. |
20070038299 | February 15, 2007 | Stone et al. |
20070041952 | February 22, 2007 | Guilak |
20070043446 | February 22, 2007 | Murray |
20070077267 | April 5, 2007 | Molz, IV et al. |
20070105222 | May 10, 2007 | Wolfinbarger et al. |
20070116734 | May 24, 2007 | Akash |
20070123843 | May 31, 2007 | Gill |
20070138042 | June 21, 2007 | Wood |
20070141105 | June 21, 2007 | Stein et al. |
20070141533 | June 21, 2007 | Ford et al. |
20070150063 | June 28, 2007 | Ruberte et al. |
20070150064 | June 28, 2007 | Ruberte et al. |
20070150068 | June 28, 2007 | Dong et al. |
20070160681 | July 12, 2007 | Park et al. |
20070161986 | July 12, 2007 | Levy |
20070162110 | July 12, 2007 | Dave |
20070166348 | July 19, 2007 | Van Dyke |
20070168021 | July 19, 2007 | Holmes, Jr. et al. |
20070185580 | August 9, 2007 | Posel |
20070185585 | August 9, 2007 | Bracy et al. |
20070190880 | August 16, 2007 | Dubrow et al. |
20070191963 | August 16, 2007 | Winterbottom et al. |
20070196419 | August 23, 2007 | Teller et al. |
20070202145 | August 30, 2007 | Ghabrial et al. |
20070203584 | August 30, 2007 | Bandyopadhyay et al. |
20070208420 | September 6, 2007 | Ameer et al. |
20070213827 | September 13, 2007 | Arramon |
20070233071 | October 4, 2007 | Dewey et al. |
20070243225 | October 18, 2007 | McKay |
20070250169 | October 25, 2007 | Lang |
20070255262 | November 1, 2007 | Haase |
20070255416 | November 1, 2007 | Melkent et al. |
20070260320 | November 8, 2007 | Peterman et al. |
20070270859 | November 22, 2007 | Companioni |
20070293948 | December 20, 2007 | Bagga et al. |
20080004704 | January 3, 2008 | Katz |
20080015578 | January 17, 2008 | Erickson et al. |
20080046082 | February 21, 2008 | Lee |
20080065218 | March 13, 2008 | O'Neil |
20080077247 | March 27, 2008 | Murillo et al. |
20080109083 | May 8, 2008 | Van Hoeck et al. |
20080119945 | May 22, 2008 | Frigg |
20080147193 | June 19, 2008 | Matthis et al. |
20080188940 | August 7, 2008 | Cohen |
20080200985 | August 21, 2008 | Robie |
20080262622 | October 23, 2008 | Butler |
20080288074 | November 20, 2008 | O'Neil et al. |
20080306609 | December 11, 2008 | Lee et al. |
20090005872 | January 1, 2009 | Moumene et al. |
20090005874 | January 1, 2009 | Fleischmann et al. |
20090024224 | January 22, 2009 | Chen et al. |
20090030399 | January 29, 2009 | Raiszadeh |
20090132051 | May 21, 2009 | Moskowitz et al. |
20090222098 | September 3, 2009 | Trieu |
20090228109 | September 10, 2009 | Pointillant et al. |
20090248162 | October 1, 2009 | Peckham |
20090254182 | October 8, 2009 | Kovarik et al. |
20090270986 | October 29, 2009 | Christensen |
20090270988 | October 29, 2009 | Snell et al. |
20090270991 | October 29, 2009 | Michelson |
20090270992 | October 29, 2009 | Gerber et al. |
20090276049 | November 5, 2009 | Weiland |
20090281517 | November 12, 2009 | Lambrecht et al. |
20090281625 | November 12, 2009 | Enayati |
20090292363 | November 26, 2009 | Goldfarb et al. |
20090317278 | December 24, 2009 | Kokubo |
20090326657 | December 31, 2009 | Grinberg et al. |
20100003639 | January 7, 2010 | Salvi et al. |
20100016970 | January 21, 2010 | Kapitan et al. |
20100042167 | February 18, 2010 | Nebosky et al. |
20100042213 | February 18, 2010 | Nebosky et al. |
20100042214 | February 18, 2010 | Nebosky et al. |
20100042215 | February 18, 2010 | Stalcup et al. |
20100042218 | February 18, 2010 | Nebosky et al. |
20100042226 | February 18, 2010 | Nebosky et al. |
20100076559 | March 25, 2010 | Bagga et al. |
20100168798 | July 1, 2010 | Clineff et al. |
20100190254 | July 29, 2010 | Chian et al. |
20100234966 | September 16, 2010 | Lo |
20100291286 | November 18, 2010 | O'Neill et al. |
20110004307 | January 6, 2011 | Ahn |
20110012280 | January 20, 2011 | Deslauriers et al. |
20110064784 | March 17, 2011 | Mullens et al. |
20110066244 | March 17, 2011 | Frasier et al. |
20110071635 | March 24, 2011 | Zhang et al. |
20110092948 | April 21, 2011 | Shachar |
20110137418 | June 9, 2011 | O'Neil et al. |
20110153028 | June 23, 2011 | Albertorio |
20110190888 | August 4, 2011 | Bertele et al. |
20110190889 | August 4, 2011 | Miller |
20110224796 | September 15, 2011 | Weiland |
20110230970 | September 22, 2011 | Lynn et al. |
20110313532 | December 22, 2011 | Hunt |
20120303128 | November 29, 2012 | Ullrich, Jr. et al. |
20120316650 | December 13, 2012 | Ullrich, Jr. et al. |
20130030529 | January 31, 2013 | Hunt |
20130190875 | July 25, 2013 | Shulock et al. |
20140264995 | September 18, 2014 | Lakshminarayanan |
20150150689 | June 4, 2015 | Wang et al. |
20150238324 | August 27, 2015 | Nebosky et al. |
20150297349 | October 22, 2015 | Butscher et al. |
20160280920 | September 29, 2016 | Seto |
20170020685 | January 26, 2017 | Geisler |
20170056179 | March 2, 2017 | Lorio |
20190053910 | February 21, 2019 | Sansur |
20190083275 | March 21, 2019 | Bell |
20190083282 | March 21, 2019 | Roeder |
4211345 | November 1993 | DE |
4423020 | January 1996 | DE |
693 28 047 | March 2000 | DE |
19904436 | August 2000 | DE |
10051438 | May 2002 | DE |
695 28 346 | September 2002 | DE |
10120330 | November 2002 | DE |
10157315 | August 2003 | DE |
0617931 | October 1994 | EP |
0827726 | March 1998 | EP |
1 273 312 | January 2003 | EP |
1 287 851 | March 2003 | EP |
1475057 | November 2004 | EP |
1806112 | July 2007 | EP |
2697155 | April 1994 | FR |
6007388 | January 1994 | JP |
7116184 | May 1995 | JP |
8173463 | July 1996 | JP |
2587625 | December 1996 | JP |
2002325781 | November 2002 | JP |
2005329179 | December 2005 | JP |
03084602 | October 2003 | WO |
03101504 | December 2003 | WO |
2005/047467 | May 2005 | WO |
2006/088480 | August 2006 | WO |
2006/135727 | December 2006 | WO |
2007/135444 | November 2007 | WO |
- Extended European Search Report dated May 23, 2019 for European Application No. 19 15 3366 (8 pages).
Type: Grant
Filed: Jan 24, 2018
Date of Patent: Nov 24, 2020
Patent Publication Number: 20180161172
Assignee: SMed-TA/TD, LLC (Columbia City, IN)
Inventors: Paul S. Nebosky (Fort Wayne, IN), Gregory C. Stalcup (Fort Wayne, IN), Troy D. Knapp (Hammond, WI)
Primary Examiner: Tessa M Matthews
Application Number: 15/878,723
International Classification: A61F 2/44 (20060101); A61F 2/30 (20060101); A61F 2/46 (20060101);